Medigard Ltd (MGZ)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Medigard Ltd (MGZ) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010950
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medigard Ltd (Medigard), formerly Medisafe Instruments Pty Ltd is a medical device company that designs and develops retractable safety medical devices. The company offers products such as auto-retractable syringe, manual retractable syringe, blood collection device, intravenous valve and flash back needle. Its blood collection device uses vacuum technology to capture the needle after the collection of blood. Medigard’s intravenous valve operates as a component for cannula and a standalone device, which is used as access points in the catheters in preference to a syringe for delivering fluid, administering drugs and taking blood samples. Its products helps to reduce the spread of blood-borne diseases including Hepatitis B, Hepatitis C and HIV or AIDS. The comapny offers its products for healthcare workers and patients. It also conducts research and development for designing a range of safety medical devices and associated products. Medigard is headquartered in Gold Coast, Queensland, Australia.

Medigard Ltd (MGZ) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medigard Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Medigard Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Medigard Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Medigard Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Medigard Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Medigard Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Medigard Enters Into Licensing Agreement With Shanghai Sol-Millennium Medical Products 10
Equity Offering 11
Medigard to Raise USD0.5 Million in Share Purchase Plan 11
Debt Offering 12
Medigard Raises USD0.18 Million in Second Tranche of Private Placement of 8% Note Due 2017 12
Medigard Raises USD0.09 Million in First Tranche of Private Placement of 8% Note Due 2017 13
Medigard Ltd – Key Competitors 14
Medigard Ltd – Key Employees 15
Medigard Ltd – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Oct 20, 2017: Medigard: Chairman Retirement and Appointment 17
Sep 14, 2017: Medigard: Resignation and Appointment of Directors 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Medigard Ltd, Medical Equipment, Key Facts, 2017 2
Medigard Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Medigard Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Medigard Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Medigard Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Medigard Ltd, Deals By Market, 2011 to YTD 2017 8
Medigard Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Medigard Enters Into Licensing Agreement With Shanghai Sol-Millennium Medical Products 10
Medigard to Raise USD0.5 Million in Share Purchase Plan 11
Medigard Raises USD0.18 Million in Second Tranche of Private Placement of 8% Note Due 2017 12
Medigard Raises USD0.09 Million in First Tranche of Private Placement of 8% Note Due 2017 13
Medigard Ltd, Key Competitors 14
Medigard Ltd, Key Employees 15

★海外企業調査レポート[Medigard Ltd (MGZ)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • First Hawaiian Inc:企業の戦略・SWOT・財務情報
    First Hawaiian Inc - Strategy, SWOT and Corporate Finance Report Summary First Hawaiian Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Central Electricity Generating Co:企業の戦略的SWOT分析
    Central Electricity Generating Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • CES Energy Solutions Corp (CEU):企業の財務・戦略的SWOT分析
    CES Energy Solutions Corp (CEU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Hanger, Inc. (HNGR)
    Hanger, Inc. (HNGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Detroit Medical Center:企業の戦略的SWOT分析
    Detroit Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Flower Orthopedics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Flower Orthopedics Corp (Flower Orthopedics) is a medical equipment provider that offers orthopedic devices. The company offers instrument kits which include K-wire kits, olive wire kits, guide wire kits, drill bit kits, lag screw kits, cannulated drill bits, trials and cannulated countersin …
  • Rockies Standard Oil Company LLC-石油・ガス分野:企業M&A・提携分析
    Summary Rockies Standard Oil Company LLC (RSOC) is an oil and gas service provider that offers exploration services for oil and gas projects in the Rockies. The company undertakes projects such as Overthrust and Hingeline, Utah and Southern Uinta and Paradox Basins, Utah. Its Southern Uinta and Para …
  • Valneva SE (VLA):企業の財務・戦略的SWOT分析
    Valneva SE (VLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Copper Mountain Mining Corporation:企業の戦略・SWOT・財務情報
    Copper Mountain Mining Corporation - Strategy, SWOT and Corporate Finance Report Summary Copper Mountain Mining Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Saniona AB (SANION):製薬・医療:M&Aディール及び事業提携情報
    Summary Saniona AB (Saniona), formerly Aniona is a research and development company that develops drugs for central nervous system diseases, autoimmune diseases, metabolic diseases and pain management. The company’s pipeline products include tesofensine, a triple monoamine reuptake inhibitor, which …
  • FMC Corp (FMC):企業の財務・戦略的SWOT分析
    FMC Corp (FMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Queen Mary University of London-製薬・医療分野:企業M&A・提携分析
    Summary Queen Mary University of London (Queen Mary), formerly Queen Mary and Westfield College, a subsidiary of University of London, is a research university that offers undergraduate and postgraduate education; and research programs. The university provides graduation and education services in ar …
  • Xtant Medical Holdings Inc (XTNT):企業の財務・戦略的SWOT分析
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowr …
  • The AES Corporation (AES)-エネルギー分野:企業M&A・提携分析
    Summary The AES Corporation (AES) is a diversified power company, which owns and operates power generating facilities. The company generates electricity through diverse fuel sources such as gas, fuel oil and coal; and renewable sources such as wind, hydro, biomass and solar. It sells the electricity …
  • Votorantim Energia Ltda:企業の戦略的SWOT分析
    Votorantim Energia Ltda - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Kesko Corp (KESKOA):企業の財務・戦略的SWOT分析
    Kesko Corp (KESKOA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • MOL Hungarian Oil and Gas Plc (MOL):企業の財務・戦略的SWOT分析
    MOL Hungarian Oil and Gas Plc (MOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Bosch Sensortec GmbH:企業の戦略的SWOT分析
    Bosch Sensortec GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Chevron Pipe Line Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Chevron Pipe Line Co (CPL), a subsidiary of Chevron Corp is an oil and gas company that operates, constructs and maintains pipeline systems for fuel transportation. The company owns and operates pipeline assets that transport refined petroleum products, liquefied petroleum gas, natural gas, …
  • China Resources Pharmaceutical Group Ltd (3320)-製薬・医療分野:企業M&A・提携分析
    Summary China Resources Pharmaceutical Group Ltd (CR Pharma), a subsidiary of China Resources (Holdings) Co Ltd is a pharmaceutical company that offers nutritional supplements. The company offers research and development, manufacture, and distribution of whole drug products. Its products comprise ch …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆